We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
-4.44%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$526M
AUM Growth
-$6.28M
Cap. Flow
+$19M
Cap. Flow %
3.61%
Top 10 Hldgs %
52.4%
Holding
409
New
43
Increased
73
Reduced
62
Closed
21

Sector Composition

Rank Sector Weight
1 Real Estate 3.13%
2 Consumer Discretionary 1.62%
3 Technology 1.26%
4 Healthcare 0.5%
5 Industrials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VDE icon
126
Vanguard Energy ETF
VDE
$9.74B
$121K 0.02%
1,129
TSLA icon
127
Tesla
TSLA
$1.3T
$119K 0.02%
330
-3
-0.9% -$934
SRE icon
128
Sempra
SRE
$54.8B
$116K 0.02%
1,382
DFAX icon
129
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.4B
$113K 0.02%
4,540
GSLC icon
130
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
$111K 0.02%
1,249
+572
+84% +$50.5K
IWN icon
131
iShares Russell 2000 Value ETF
IWN
$14.6B
$110K 0.02%
681
GM icon
132
General Motors
GM
$76.8B
$109K 0.02%
2,500
SPEM icon
133
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$108K 0.02%
2,802
VUG icon
134
Vanguard Morningstar Growth ETF
VUG
$231B
$104K 0.02%
2,166
QQQJ icon
135
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.18B
$102K 0.02%
3,502
+107
+3% +$3.14K
TROW icon
136
T. Rowe Price
TROW
$24.3B
$100K 0.02%
660
EFG icon
137
iShares MSCI EAFE Growth ETF
EFG
$17.3B
$96K 0.02%
1,000
VRTX icon
138
Vertex Pharmaceuticals
VRTX
$126B
$89K 0.02%
342
-12
-3% -$2.85K
ABBV icon
139
AbbVie
ABBV
$435B
$88K 0.02%
544
+28
+5% +$4.07K
NUE icon
140
Nucor
NUE
$62.1B
$88K 0.02%
590
-127
-18% -$15.6K
IJH icon
141
iShares Core S&P Mid-Cap ETF
IJH
$127B
$85K 0.02%
1,580
+255
+19% +$13.6K
TMO icon
142
Thermo Fisher Scientific
TMO
$220B
$84K 0.02%
143
+72
+101% +$41.4K
SPLV icon
143
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$83K 0.02%
1,230
CLF icon
144
Cleveland-Cliffs
CLF
$6.99B
$82K 0.02%
2,558
UNH icon
145
UnitedHealth
UNH
$370B
$80K 0.02%
156
+101
+184% +$48.7K
HD icon
146
Home Depot
HD
$355B
$79K 0.02%
264
FSTR icon
147
Foster
FSTR
$432M
$77K 0.01%
5,000
LOW icon
148
Lowe's Companies
LOW
$125B
$73K 0.01%
359
+101
+39% +$23.2K
STLD icon
149
Steel Dynamics
STLD
$37.6B
$73K 0.01%
871
+3
+0.3% +$202
UNP icon
150
Union Pacific
UNP
$174B
$72K 0.01%
264
+163
+161% +$41.2K

Similar funds

Roble Belko & Company's Q1 2022 Portfolio in Review

As of Q1 2022, Roble Belko & Company held 409 positions worth $526M, down 1.2% from $532M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Roble Belko & Company deployed $19M of net new capital in Q1 2022, opening 43 new positions and adding to 73 existing holdings. Its largest new stake was Ares Commercial Real Estate: 140,452 shares worth $2.18M.

By sector, the portfolio is most concentrated in Real Estate at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Vanguard Ultra-Short Bond ETF, an estimated $16M trimmed.

  • Roble Belko & Company's largest Q1 2022 buy was Ares Commercial Real Estate: 140,452 shares worth $2.18M.
  • Roble Belko & Company added most to JPMorgan Ultra-Short Income ETF in Q1 2022, an estimated $13.9M increase.
  • Roble Belko & Company's biggest Q1 2022 reduction was Vanguard Ultra-Short Bond ETF, cutting an estimated $16M.
  • Roble Belko & Company fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q1 2022, selling an estimated $381K.
  • Roble Belko & Company's ten largest holdings make up 52% of its $526M portfolio in Q1 2022.
  • Roble Belko & Company opened 43 new positions and closed 21 in Q1 2022.
  • Roble Belko & Company's portfolio value fell 1.2% quarter-over-quarter to $526M.

Based on Roble Belko & Company's 13F filing for Q1 2022, filed 6 May 2022.